DAWN vs GIS · rev $131.2M vs P/E 8.2, rev $18.42B
Day One Biopharmaceuticals Inc (DAWN) versus General Mills Inc (GIS) — a side-by-side from cached financials, not a winner call.
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
Latest reported GIS revenue for 2026-05-31 was $18.42B. Net income was -$87.6M. Revenue was up 304.4% from 2025-05-25 to 2026-05-31. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
DAWN currently screens at market cap $656.8M. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Not investment advice. Open the DAWN and GIS stock pages for the full models.
Not investment advice.